Earth Science Tech, Inc. filings document formal public-company disclosures for a Florida issuer with common stock quoted over the counter. The record includes Form 8-K reports covering Regulation FD releases, financial-result announcements, the launch of MyOnlineConsultation.com through MOCTeledoc, and the company’s SIC 2834 pharmaceutical classification.
Other filings disclose governance and capital-structure matters, including bylaw amendments for electronic shareholder notices, officer and director compensation arrangements, auditor changes, investor-relations engagement, and the registered class of ETST common stock. These documents tie the company’s healthcare portfolio disclosures to its reporting controls, board practices and OTC security status.
Earth Science Tech, Inc. reports another profitable year, growing revenue to $35.7 million and net income to $3.6 million for the year ended March 31, 2026. The health and wellness holding company, built around compounding pharmacies, telemedicine and a small consumer brand, generated a 71% gross margin.
Operating expenses rose 6% as marketing more than tripled to support growth, while salaries and general and administrative costs declined. Cash from operations was $1.9 million, funding $1.9 million of investment and $0.7 million of financing outflows, including stock repurchases.
Total liabilities fell to $1.9 million and long‑term debt was eliminated, helping boost total equity to $7.0 million. The company repurchased and cancelled shares, and states it has not issued equity since early 2023, emphasizing non‑dilutive financing and an authorized $10 million share repurchase program.
Earth Science Tech, Inc. provided a shareholder update highlighting major milestones for the fiscal year ended March 31, 2026. The company reports repurchasing over 6.9 million shares of common stock since fiscal Q1 2026 and states it has been cash flow positive across its operating platform while pursuing debt-free growth.
The Health/Wellness segment is described as the core operating engine expected to generate most revenue, with Peaks Curative surpassing $2 million in revenue in the first week of fiscal Q4 2026. Management also notes three additional properties under development awaiting final permits and says 3,150,392 shares of common stock have been retired quarter-to-date, positioning the company, in its view, in real financial strength entering the new fiscal year.
Earth Science Tech, Inc. reported that its Board of Directors amended Article I, Section 4 of its Bylaws, effective April 16, 2026. The change permits delivery of shareholder meeting notices by electronic transmission, including email, to modernize corporate governance, improve administrative efficiency, and reduce printing and mailing costs. The amended bylaw language is set out in a Board Resolution filed as Exhibit 3.1 to this report.
Earth Science Tech, Inc. reports the launch of MyOnlineConsultation.com through its MOCTeledoc, LLC division, completing what it describes as a fully vertically integrated telehealth and pharmacy ecosystem. MOCTeledoc is introduced as a doctor network that provides both technology and clinical staffing to digital health companies.
The company states that MOCTeledoc was cash-flow-positive during its beta phase and is expected to be immediately accretive to earnings as it is rolled out nationwide. Management highlights that offering the custom telehealth platform and prescriber network as a turnkey service creates a new revenue stream and a funnel to Earth Science Tech’s in-house compounding pharmacies.
The filing also reiterates that Earth Science Tech is a diversified health and wellness holding company operating compounding pharmacies, telemedicine platforms, targeted healthcare facilities, a real estate and asset management arm, a consumer products brand, and a non-profit foundation supporting patient prescription costs.
Earth Science Tech, Inc. reported that on March 11, 2026 it mutually agreed to renew the employment agreements of Chief Financial Officer Ernesto L. Flores and Chief Technology Officer Christopher A. Rose for an additional one-year term.
The original agreements were entered into on March 11, 2025, and all other material terms and conditions remain unchanged and in full force and effect.
Earth Science Tech, Inc. reported a change in its independent auditor. On February 17, 2026, Stephano Slack LLC resigned as the company’s independent registered public accounting firm. Its prior audit reports for the year ended March 31, 2025 contained no adverse opinions, disclaimers, or qualifications.
The company states there were no disagreements or reportable events with Stephano Slack under SEC Regulation S-K during the referenced periods. Also on February 17, 2026, Earth Science Tech engaged Semple, Marchal & Cooper, LLP as its new independent PCAOB auditor for the fiscal year ending March 31, 2026 and issued a press release describing this engagement.
Earth Science Tech, Inc. reported a strong third fiscal quarter 2026 with revenue of $8.4 million, up 14.1% year-over-year, and gross margin expanding to 76.3% from 69.2%. Net income jumped to $910,000 from $206,000, while Adjusted EBITDA rose to $1.2 million from $0.3 million.
The Company highlighted improving balance sheet quality, with total assets of $8.1 million, working capital of $773,000, no bank debt, and 3.7 million shares repurchased and retired over nine months. Multiple operating units are generating positive cash flow, and Peaks, its telemedicine platform, surpassed $2.0 million in revenue in under a year.
Management and the Board announced governance and cost initiatives expected to deliver approximately $1.4 million in annualized savings, supporting an increase in net income from about $3.3 million in fiscal 2025 to a projected $4.7 million in fiscal 2026. Actions include voiding CEO and COO employment contracts, waiving variable pay in the interim, reducing Board meeting fees to $2,000, planning a non-binding say-on-pay vote, evaluating retirement of Series B preferred stock, and targeting divestiture of non-core assets.
Earth Science Tech, Inc. reported stronger results for the quarter ended December 31, 2025. Revenue for the quarter rose to $8.39 million from $7.35 million, lifting gross profit to $6.40 million and expanding gross margin to 76% from 69%. Net income for the quarter increased to $0.91 million from $0.21 million, while nine-month net income grew to $2.31 million from $2.08 million on revenue of $26.20 million versus $24.44 million. Total assets reached $8.09 million with liabilities of $2.29 million and stockholders’ equity of $5.80 million. Operating cash flow was $1.06 million for the nine months, with cash declining to $0.42 million after investment spending and share repurchases. The company continued building its healthcare and telemedicine platform through the acquisitions of Las Villas Health, DOConsultations, and 80% of Magnefuse, and repurchased about 3.7 million shares for $0.65 million.
Earth Science Tech, Inc. filed a current report to disclose that it has issued a press release about an industry classification update. On January 6, 2026, the company announced a directive industry classification update to Standard Industrial Classification (SIC) code 2834, which is used for pharmaceutical-related entities. The disclosure notes that the company has formally identified as a pharmaceutical entity since 2022. The press release describing this classification update is included as an exhibit to the report.
Earth Science Tech, Inc. reported that on January 5, 2026 it issued a press release announcing its engagement with Hayden IR. The company furnished this update as an "Other Event" and attached the full press release as Exhibit 99.1 to provide additional detail about the new engagement.